- Home
- BCML vs NMRA Comparison
BCML vs NMRA Comparison
Compare BCML & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BCML | NMRA |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.1M | 424.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | BCML | NMRA |
|---|---|---|
| Price | $29.85 | $1.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $32.00 | $8.00 |
| AVG Volume (30 Days) | 23.5K | ★ 947.9K |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | ★ 4.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.10 | N/A |
| Revenue | ★ $94,896,000.00 | N/A |
| Revenue This Year | $0.51 | N/A |
| Revenue Next Year | $10.33 | N/A |
| P/E Ratio | $14.22 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.22 | $0.61 |
| 52 Week High | $33.15 | $11.51 |
Technical Indicators
Market Signals| Indicator | BCML | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 44.74 | 37.30 |
| Support Level | $29.18 | $1.73 |
| Resistance Level | $33.15 | $1.93 |
| Average True Range (ATR) | 1.03 | 0.11 |
| MACD | -0.33 | -0.01 |
| Stochastic Oscillator | 11.08 | 20.00 |
Price Performance
Historical ComparisonAbout BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.